The overall effect size from the random effect model meta-analysis showed a reduction in the level of CRP in T2DM patients post-treatment compared to at baseline [SMD = −1.80, 95% CI (−2.76, −0.84), p ˂ 0.001] (Figure 3). Here, CRP is linked to type 2 diabetes mellitus.